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Gene inactivation by transposon insertion or allelic
exchange is a powerful approach to probe gene
function. Unfortunately, many microbes, including
Chlamydia, are not amenable to routine molecular
genetic manipulations. Here we describe an arrayed
library of chemically induced mutants of the geneti-
cally intransigent pathogen Chlamydia trachomatis,
in which all mutations have been identified by
whole-genome sequencing, providing a platform for
reverse genetic applications. An analysis of possible
loss-of-function mutations in the collection uncov-
ered plasticity in the central metabolic properties of
this obligate intracellular pathogen.We also describe
the use of the library in a forward genetic screen that
identified InaC as a bacterial factor that binds
host ARF and 14-3-3 proteins and modulates F-actin
assembly and Golgi redistribution around the patho-
genic vacuole. This work provides a robust platform
for reverse and forward genetic approaches in
Chlamydia and should serve as a valuable resource
to the community.
INTRODUCTION
Advances in genome sequencing technologies enable the
cost-effective sequencing of microbial genomes (Markowitz
et al., 2012), many of which are recalcitrant to genetic anal-
ysis. As a result, the function of individual genes in these mi-
crobes is often inferred based on their homology to genes in
model organisms where molecular genetic approaches, such
as insertional mutagenesis or gene replacement, are standard.
However, the development of a robust system for DNA trans-
formation and the molecular tools to perform targeted muta-
genesis in many microbes can be a lengthy process or may
be unattainable. For instance, Chlamydia trachomatis, an
intracellular bacterial pathogen responsible for blinding716 Cell Host & Microbe 17, 716–725, May 13, 2015 ª2015 Elsevier Itrachoma and sexually transmitted infections (Haggerty
et al., 2010), was only recently reported to be amenable to
DNA transformation and limited molecular genetic manipula-
tion (Heuer et al., 2007; Kari et al., 2011; Wang et al., 2011;
Nguyen and Valdivia., 2012; Johnson and Fisher., 2013),
even though the organism was first cultured more than half a
century ago.
The Chlamydia life cycle (Figure S1) alternates between an
infectious elementary body (EB) and an intracellular replicative
reticulate body (RB). Upon internalization, the EB modifies its
membrane-bound vacuole to generate a compartment termed
the inclusion (Hatch, 1999).Within the inclusion, EBs differentiate
into RBs, replicate, and eventually differentiate back into EBs,
which are released to initiate new rounds of infections
(Dautry-Varsat et al., 2005). Fromwithin the inclusion,Chlamydia
manipulates host cellular pathways to ensure its proliferation and
survival (Bastidas et al., 2013), including changes to the
organization of the host cell’s internal architecture such as the
redistribution of organelles and cytoskeletal elements around
the inclusion (Kokes and Valdivia, 2012). Given the lack of robust
tools for molecular genetic manipulation in C. trachomatis, the
bacterial genes underlying these cellular changes, their contribu-
tion to Chlamydia pathogenesis, and the ensuing metabolic
adaptations to the intracellular environment remain poorly
understood.
In this work we generated and characterized a collection
of chemically mutagenized C. trachomatis strains in which all
induced gene variants were identified by whole-genome
sequencing (WGS). In addition to providing a robust frame-
work for reverse genetic applications, an analysis of variant
alleles led to insights into the metabolic requirements of
Chlamydia during infection of mammalian cells. Finally, we
implemented a microscopy-based forward genetic screen
and identified a bacterial factor important for regulating
cytoskeletal rearrangements at the periphery of the inclusion.
We find that this ARF and 14-3-3-recruiting factor also medi-
ates Golgi reorganization, yet is dispensable for trafficking of
Golgi-derived sphingolipids to the inclusion. Overall, our
work illustrates the value of combining standard chemical
mutagenesis and WGS as a platform for reverse and forward
genetics applications.nc.
Figure 1. Generation of an Ordered Array of
Sequenced C. trachomatis Mutants for Use
in Genetic Analyses
(A) Chemically mutagenized C. trachomatis (C. t)
LGV-L2 434/Bu strains were clonally isolated by
plaque purification and arrayed in 96-well plates.
Genomic sequencing libraries from a pool of 20
mutant strains and one reference strain were
tagged with a unique barcode, combined with four
other pools, and sequenced on an Illumina NGS
platform.
(B) Distribution of synonymous (green), non-syn-
onymous (gray), nonsense (red), and non-coding
(white) single-nucleotide variants (SNVs) identified
among mutagenized C. t strains.
(C) Distribution of ORFs without variant alleles
(2%, black), with alleles harboring only synony-
mous SNVs (2%, green), containing both synony-
mous and non-synonymous SNVs (96%, gray),
and with nonsense SNVs (10%, red).
(D) Density of SNVs (number of SNVs/10 kb of
DNA sequence) across the C. t LGV-L2 genome.
* denotes rRNA paralogs (CTL_r01_2 CTL_r02_2).
Underrepresentation of SNVs is due to an inability
to unambiguously map sequencing reads to these
loci.
(E) Distribution of the number of variant alleles
identified per ORF.RESULTS
ACollection of Chemically Mutagenized and Sequenced
Strains Provides a Broad Array of Mutant Alleles in
C. trachomatis
To facilitate a dissection of C. trachomatis traits important for
infection and manipulation of host cellular targets, we subjected
a rifampin-resistant (RifR) lymphogranuloma venereum (LGV)
C. trachomatis L2 strain (L2/434/Bu) to ethyl methyl sulfonate
(EMS) or N-ethyl-N-nitrosourea (ENU) mutagenesis. We isolated
variants that exhibited a small plaque phenotype as these mu-
tants are more likely to have been exposed to high mutagenic
doses. From initial WGS of 43 mutant strains, we determined
that the number of chemically induced genetic lesions per
genome ranged from 7 to 25 and from 6 to 22 transitions for
EMS- and ENU-treated strains, respectively. We expanded
each clonal isolate in Vero cells and arrayed them into a collec-
tion of 934 strains (Figure 1A). Because plaque isolation and
clonal expansion requires a complete infectious cycle (Fig-Cell Host & Microbe 17, 716–ure S1), these mutants are unlikely to be
biased for defects in any one specific
stage of infection.
This strain collection would constitute
a useful platform for reverse genetics
applications if all mutagen-induced sin-
gle nucleotide variants (SNVs) could be
identified and mapped. We enriched
Chlamydia DNA from infected Vero cells,
pooled DNA from 20 strains (Table S1),
and sequenced five barcoded pools
totaling 100 strains in an Illumina
HiSeq 2000 Next Generation Sequencing(NGS) platform (Figure 1A) leading to an average of 14X–94X
coverage per genome (data not shown). We used SNVer (single
nucleotide variant caller), a program developed to identify vari-
ants from pooled NGS data (Wei et al., 2011), and identified
8,205 SNVs (Table S2). Among these variants, 2,212 SNVs
(27%) were not predicted to incur amino acid substitutions in
the corresponding protein sequences (synonymous) (Figure 1B).
Variants mapping to non-protein-coding regions of the genome
(intergenic regions, rRNA, tRNA loci) were underrepresented
(10%) (Figure 1B), likely due to the high coding density of the
C. trachomatis L2 genome (Thomson et al., 2008). In contrast,
non-synonymous variants were predominant (5,061 SNVs,
62%) (Figure 1B), which can lead to production of ‘‘neutral’’
protein variants that are functionally indiscernible from their
wild-type (WT) counterparts or to ‘‘non-neutral’’ amino acid sub-
stitutions that can be deleterious for protein function, folding, or
stability. We assessed the impact of these variants on gene
product function by applying SNAP (screening for non-accept-
able polymorphisms), a neural network-based method that725, May 13, 2015 ª2015 Elsevier Inc. 717
measures the likelihood that non-synonymous amino acid sub-
stitutions have a neutral or non-neutral impact on protein func-
tion (Bromberg and Rost, 2007). We identified 2,842 neutral
(35%) and 2,219 non-neutral (27%) non-synonymous SNVs
(Table S2). In addition, we identified 99 mutations (1%) (Fig-
ure 1B, Table S3) that lead to nonsense codons and presumably
non-functional truncated proteins.
The C. trachomatis 434/Bu genome encodes 889 ORFs (pro-
tein-coding genes) and 54 non-protein-coding genes (tRNAs,
rRNAs, and pseudogenes) (Thomson et al., 2008). We find that
for 21 ORFs (21/889, 2%), we did not identify alleles harboring
SNVs and that for 18 ORFs (18/889, 2%), we only identified
alleles harboring synonymous SNVs (Figure 1C). Nonetheless,
since we identified alleles with non-synonymous SNVs for 96%
(853/889) of ORFs in the genome, including alleleswith nonsense
mutations for 84 protein coding genes (Figure 1C), our collection
of mutants provides a broad representation of the possible
mutational landscape of C. trachomatis. SNVs were widely
distributed throughout the chromosome at a density of 8
SNVs/kb with the exception of the orthologous rRNA operons
(CTL_r01/CTL_r02), which were excluded from our SNV calling
workflow due to the inability to unambiguously map sequence
reads to this region (Figure 1D). We generated more than one
distinct mutant allele for the majority of coding genes in the
C. trachomatis chromosome with mutant allele frequencies
ranging from 1 to 49 variant alleles/ORF (Figure 1E, Table S2).
This collection of SNVs allows us to quickly identify strains
bearing mutant alleles in any gene of interest. These strains
can be then phenotyped to define the function of the mutated
gene (‘‘reverse genetics’’), as we have reported for the effectors
CPAF and TepP (Snavely et al., 2014; Chen et al., 2014).
The C. trachomatis LGV L2 Biovar Tolerates
Perturbations in Metabolic and DNA Damage Repair
Pathways
Based on 99 nonsense mutations in 84 ORFs, we can predict
physiological properties inherent to C. trachomatis, such as the
ability to tolerate alterations in central metabolism, amino acid
metabolism and transport, membrane transport and stability,
DNA processing, and transcription (Table S3). In addition, these
nonsense alleles suggest that severalChlamydia proteins postu-
lated to interact with host factors also appear to be dispensable
for completion of its life cycle (Table S3). These include putative
inclusion membrane proteins and effectors such as the mamma-
lian histone methyltransferase NUE (Pennini et al., 2010), the
early-translocated scaffolding phosphoprotein TepP (Chen
et al., 2014), the lipid droplet-associated protein Lda2 (Kumar
et al., 2006), and the protease CPAF (Zhong, 2009, 2011). The
recovery of three CPAF null alleles in our collection is consistent
with findings indicating that the function of this protease is more
nuanced during infection than previously appreciated (Chen
et al., 2012; Snavely et al., 2014). While every nonsense allele
we have characterized has led to a loss of gene product produc-
tion (data not shown), we cannot exclude the possibility that
some alleles can still code for partially functional proteins.
Based on these nonsense mutations, we inferred which bio-
logical pathways are not necessary for Chlamydia to complete
its infectious cycle in a cell culture model of infection. For
instance, recovery of nonsense mutations in glgB and glgX718 Cell Host & Microbe 17, 716–725, May 13, 2015 ª2015 Elsevier Iprovide genetic confirmation that Chlamydia does not require
the synthesis and breakdown of branched glycogen in cell cul-
ture (Figure 2A) as previously suggested (Matsumoto et al.,
1998; Nguyen and Valdivia, 2012). Similarly, the breakdown of
glucose-6-phosphate into pyruvate by the Embden-Meyerhoff-
Parnas (EMP or glycolysis) pathway is expendable, as indicated
by a loss-of-function mutation in glucose-6-phosphate isom-
erase (pgi), an enzyme that channels glucose-6-phosphate into
the EMP pathway (Figure 2B). Based on metabolic pathways
inferred from the C. trachomatis L2 genome, we hypothesize
that the breakdown of glucose-6-phosphate in a pgi null strain
can be restored by the non-oxidative branch of the pentose
phosphate pathway (Figure 2B).
In most bacteria, the TCA cycle is important for the generation
of reductive potential, energy generation, and the synthesis of
metabolic precursors. The TCA cycle in C. trachomatis is incom-
plete given the lack of citrate synthase (gltA), aconitase (acn),
and isocitrate dehydrogenase (icd) (McClarty, 1999). In the
absence of a complete TCA cycle, production of oxaloacetate
is likely fueled either by the import of 2-oxoglutarate from the
host by the Chlamydia homolog of a dicarboxylate translocator
(SodTi) (Weber et al., 1995), or by deamination of glutamate
into 2-oxoglutarate (Weiss, 1967). Under cell culture conditions,
glutamate does not appear to be necessary, since we isolated
a strain containing a nonsense mutation in the putative gluta-
mate transporter-encoding gene (gltT) (Figure 2C). Interestingly,
the TCA cycle is further constrained in C. trachomatis LGV bio-
vars, since the fumarate hydratase enzyme that catalyzes the
conversion of fumarate to malate is encoded by a pseudogene
(Thomson et al., 2008), suggesting that a continuous cycle
beginning with 2-oxoglutarate and ending with oxaloacetate is
not required. Consistent with this, we identified a nonsense
mutation in sucA (Figure 2C), encoding the E1 subunit of the
2-oxoglutarate-dehydrogenase complex that catalyzes the
decarboxylation of 2-oxoglutarate to succinate. Therefore, in
addition to being unable to synthesize malate, the Chlamydia
LGV L2 biovar can also survive without succinate and fumarate
(Figure 2C).
C. trachomatis can also propagate in cultured cells without a
functional DNA mismatch repair system or with an impaired
nucleotide excision DNA repair pathway (Figures 2D and 2E).
C. trachomatis is hypothesized to employ a methylation-inde-
pendent mismatch repair pathway (reviewed in Larrea et al.,
2010; Pillon et al., 2010) as they lack dam and mutH (Stephens
et al., 1998; Carlson et al., 2005; Thomson et al., 2008). Instead,
mismatch repair is postulated to be mediated by the mismatch-
sensing protein MutS and the repair protein MutL (reviewed in
Schofield and Hsieh, 2003; Kunkel and Erie, 2005). Interestingly,
we identified nonsense mutations in mutS and mutL indicating
that under normal growth conditions in cultured cells there is
not sufficient DNA damage such that the sensing and repair
functions provided by MutS and MutL are required (Figure 2E).
Nucleotide excision repair (NER) allows for repair of drug and
UV-induced lesions to DNA by the UvrABC excinuclease com-
plex (reviewed in Morita et al., 2010). NER repairs damage in
both transcribed and untranscribed DNA strands (global
genomic NER [GG-NER]) and repairs damaged DNA when
RNA polymerase stalls at a lesion in DNA (transcription-coupled
repair [TC-NER]) (Selby and Sancar, 1994; Svejstrup, 2002). Asnc.
Figure 2. C. trachomatis Tolerates Pertur-
bations in the Tricarboxylic Cycle and DNA
Repair Networks
(A–C) The LGV C. t central carbon metabolic
network. The distribution of all synonymous
(green), neutral (yellow), non-neutral (orange), and
nonsense (red) bearing alleles is depicted for each
ORF in the network. Distributions are normalized
to total number of SNV bearing alleles identified
per ORF. All ORFs with observed nonsense alleles
are shaded in light red. Production and breakdown
of branched glycogen is not necessary as LGVC. t
tolerates nonsense mutations in glgB and glgX (A).
The presence of a nonsense mutation in pgi sug-
gests that the pentose phosphate pathway is
sufficient to circumvent loss of fructose-6-
phosphate production when the EMP pathway
(glycolysis) is blocked (B). Nonsense mutations in
glt and sucA suggest that LGV biovars can sustain
metabolic activity with a severely curtailed TCA
cycle (C). The TCA cycle is further truncated due to
the presence of a fumC (dashed box) pseudogene.
All compounds imported from the host are shown
in blue.
(D) LGV C. t biovars can tolerate defects in their
DNA mismatch repair machinery as suggested by
the presence of nonsense bearing alleles in mutS
and mutL.
(E) Defects in the nucleotide excision repair
pathway are also tolerated as evidenced by the
presence of nonsense bearing alleles in uvrA
and uvrC.observed with mismatch repair, the identification of uvrA and
uvrC nonsense mutations imply that both GG-NER and TC-NER
are dispensable for C. trachomatis in epithelial cells (Figure 2D).
The Inclusion Membrane Protein InaC Is Necessary for
F-Actin Assembly at the Inclusion Periphery
An arrayed C. trachomatis mutant library is also a valuable
resource for forward genetic approaches to identify mutants
impaired for specific cellular traits. To illustrate this application,
we implemented a microscopy-based screen to identify bacte-
rial factors mediating rearrangement of filamentous actin
(F-actin) at the periphery of the inclusion in infected cells (Kumar
and Valdivia, 2008).
We screened for mutants that failed to promote F-actin
assembly at the inclusion and identified two strains,
CTL2M0407 (Figure 3A) and CTL2M0448 (data not shown, see
below) that displayed a reproducible defect in this cytoskeletal
reorganization. Since the genomes of these mutants wereCell Host & Microbe 17, 716–sequenced in pools and the exact num-
ber of SNVs in each strain was unknown,
we re-sequenced the genomes of both
strains and determined them to be iden-
tical (Table S4). Consequently, we chose
CTL2M0407 (herein referred to as M407)
for further characterization. M407 har-
bors 12 non-synonymous variants as
compared to the reference genome
(Table S4). By performing geneticcrosses between M407 (RifR) and a spectinomycin-resistant
(SpcR) WT strain (Nguyen and Valdivia, 2012), we identified a
nonsense mutation in CTL0184 (C307T/Q103*) as responsible
for the failure to promote F-actin assembly at inclusions (Fig-
ure S2). Western blot analysis and immunofluorescence micro-
scopy with antibodies raised against the inclusion membrane
protein CT813 (homolog of CTL0184 in C. trachomatis Serotype
D [Chen et al., 2006; Li et al., 2008]) confirmed the absence of
CTL0184 in M407 (Figures 3B and 3C). Given the genetic link be-
tween the CTL0184C307T allele, the lack of detectable CTL0184
gene product, and the loss of F-actin assembly to the inclusion,
we renamed CTL0184 as InaC (inclusion membrane protein for
actin assembly) to reflect its role in F-actin re-programming.
To confirm InaC’s role in F-actin rearrangements, we trans-
formed M407 with a plasmid shuttle vector encoding WT inaC
under the control of its endogenous promoter. Transformation
restored InaC production in M407 (Figures 3B and 3C) and
F-actin assembly at the inclusion (Figure 3C). We found that725, May 13, 2015 ª2015 Elsevier Inc. 719
Figure 3. The Inclusion Membrane Protein
InaC Is Required for F-Actin Assembly at
the Inclusion
(A) F-actin assembly at inclusions (arrowhead) is
absent in HeLa cells infected with M407. F-actin
(grayscale) and C. t (red) were detected by indirect
immunofluorescence at 30 hpi using rhodamine-
phalloidin and anti-MOMP antibodies, respec-
tively. DNA (blue) was stained with Hoechst.
(B–E) F-actin assembly in M407 inclusions is
rescued upon expression of WT InaC. InaC
expression is restored in M407 mutants trans-
formedwith a plasmid expressingWT inaC from its
own promoter as assessed by immunoblot (C) and
immunofluorescence (red, D) analysis and without
affecting the distribution of another inclusion
membrane protein, IncG. F-actin assembly at the
inclusion (white arrowheads, C) is restored in
M407 transformed with a plasmid encoding inaC
but not an empty vector. Note that the average
intensity (D) and frequency (E) of F-actin around
complemented inclusions is comparable to WT.
Mean ± SEM for three independent experiments is
shown. At least 50 (F) or 300 (E) inclusions were
enumerated in each triplicate for each experiment.
* indicates p < 0.05 by one-way ANOVA and
Newman-Keuls post hoc. Scale bars represent
10 mm.both the amounts of F-actin (Figure 3D) and the frequency
of F-actin structures at inclusions in M407 (Figure 3E) were
restored to WT levels after transformation with an InaC-
expressing plasmid but not an empty vector control. We
conclude that InaC is required for F-actin assembly around the
C. trachomatis inclusion.
InaC Recruits ARF and 14-3-3 Proteins to the Inclusion
To define the function of InaC, we identified interacting host
proteins by immunoprecipitating a GFP-tagged full-length InaC
transiently expressed in HEK293T cells. Ten of the 19 interacting
proteins identified by mass spectrometry (Table S5) belong to
two protein families: human ADP-ribosylation factors (ARF1, 4
and 5) and 14-3-3 proteins (Figure 4A). We confirmed the co-pre-
cipitation of GFP-InaC with endogenous 14-3-3b, 14-3-3ε, and
ARF1 by immunoblot analysis (Figure 4B). ARFs are small
GTPases that function in vesicular traffic and secretory organelle
function (Donaldson and Jackson, 2011), and 14-3-3s are a fam-
ily of conserved regulatory proteins that bind and regulate
signaling proteins in numerous cellular pathways (Morrison,
2009). Given that GFP-ARF1 and 14-3-3b localize to the inclusion
periphery (Moorhead et al., 2010; Scidmore and Hackstadt,
2001), we tested if InaC mediates recruitment of ARFs and720 Cell Host & Microbe 17, 716–725, May 13, 2015 ª2015 Elsevier Inc.14-3-3s by assessing the localization
of GFP-ARFs (ARF1, 4, 5, and 6) and
endogenous 14-3-3b and 14-3-3ε
in cells infected with WT C. trachomatis
or InaC mutants (Figure 4C). 14-3-3b
and 14-3-3ε are enriched around WT
inclusions, yet are barely detectable
around inclusions lacking InaC. Similarly,
GFP-ARF1, -ARF4, and -ARF5 (primarilyGolgi-localized ARFs) are recruited to inclusions in an InaC-
dependent manner, while ARF6 (plasma membrane and endo-
some localized ARF) is not (D’Souza-Schorey and Chavrier,
2006; Donaldson and Jackson, 2011) (Figure 4C). Strikingly, the
localization of ARF1, 4, and5and14-3-3 to inclusions ismarkedly
increased in strains overexpressing InaC (Figure 4C). These data
suggest that InaC is necessary for and mediates the recruitment
of 14-3-3s and Golgi-specific ARFs to the inclusion.
Golgi Redistribution around the Inclusion Requires InaC
and F-Actin
The Golgi apparatus is a dynamic membrane system in which
organelle architecture and membrane traffic are fundamentally
linked (Lippincott-Schwartz et al., 1998). ARFs are mediators
of vesicular traffic within this system and critical for maintaining
Golgi structure and identity (Donaldson and Jackson, 2011;
Lippincott-Schwartz et al., 1998). The actin cytoskeleton sup-
ports membrane traffic within the secretory system and is
directly involved in the maintenance of Golgi architecture (Egea
et al., 2006). InC. trachomatis-infected cells, the Golgi fragments
into ministacks that envelop the inclusion (Heuer et al., 2009).
Since InaC recruits ARFs and is required for F-actin assembly
at the inclusion, we tested if InaC plays a role in modulating Golgi
Figure 4. The Recruitment of ARF and 14-
3-3 Proteins and Golgi Redistribution to
the Inclusion Requires InaC
(A and B) ARF and 14-3-3 proteins interact with
InaC. Lysates from HEK293T cells expressing
either GFP or a GFP-InaC fusion protein were
incubated with GFP-Trap resin. Bound proteins
were identified by LC-MS/MS (Table S5). Proteins
of ARF and 14-3-3 families are shown with corre-
sponding accession numbers (A). The specificity
of these interactions was confirmed by SDS-
PAGE followed by western blot with specific
antibodies (B).
(C) InaC mediates the recruitment of 14-3-3b,
14-3-3ε, and Golgi-specific ARF GTPases to the
inclusion. HeLa cells were infected with the indi-
catedC. t strains and either processed at 30 hpi for
immunofluorescence using anti-14-3-3 antibodies
(left) or transfected with EGFP-ARF isoforms for
24 hr before processing at 30 hpi for microscopy
(right). Note that the intensity of 14-3-3 and ARF1,
4, and 5 recruitment to inclusions correlates with
InaC expression. The divergent ARF6 was not
recruited to inclusions or bound to GFP-InaC.
(D and E) Golgi redistribution around the inclusion
requires InaC. HeLa cells were infected as in (C)
and processed at 30 hpi for immunofluorescence
using anti-GM130 (grayscale), anti-IncG (red) an-
tibodies, and Hoechst (blue), and the frequency of
Golgi distribution was quantified. Golgi distribu-
tion at least halfway around inclusions was scored
as a positive (E), as detailed in Supplemental
Experimental Procedures and Figure S3A.
(F) F-actin assembly is required for Golgi redistri-
bution at inclusions. HeLa cells were infected with
a WT LGV-L2 strain and treated with 500 nM
Latrunculin B for 30min before processing as in (E)
at 30 hpi. Mean ± SEM for three independent
experiments is shown. At least 40 (E) or 90 (F)
inclusions were enumerated in each triplicate for
each experiment. * indicates p < 0.05 by one-way
ANOVA and Newman-Keuls post hoc (E) or Stu-
dent’s t test (F). Scale bars represent 10 mm.architecture duringC. trachomatis infection. The Golgi appeared
distributed at least halfway around 40% of WT inclusions (Fig-
ures 4D and 4E, Figure S3A). In contrast, the Golgi retained a
compact morphology at a perinuclear region adjacent to
inclusions lacking InaC. Given the importance of F-actin in main-
taining the shape of the Golgi in mammalian cells (Egea et al.,
2006), we tested whether Golgi redistribution around the inclu-
sion is dependent on F-actin. TheGolgi was no longer distributed
around WT inclusions treated with the F-actin polymerization in-
hibitor Latrunculin B (Figure 4F). These results indicate that Golgi
redistribution around C. trachomatis inclusions requires InaC
and intact actin filaments.
InaC-Mediated Golgi Redistribution Is Dispensable for
Chlamydia Sphingolipid Acquisition and Growth
Since vesicular traffic through the Golgi and via ARF-regulated
pathways delivers sphingolipids to Chlamydia (Elwell et al.,
2011; Hackstadt et al., 1996), and Golgi redistribution around in-Cell Hclusions has been proposed to facilitate sphingolipid acquisition
by Chlamydia (Heuer et al., 2009; Rejman Lipinski et al., 2009),
we assessed whether InaC contributes to Chlamydia growth
and its ability to acquire sphingolipids (Figure S3). While we
found a 3-fold decrease in the recovery of infectious progeny
due to background mutations in M407 compared to its WT RifR
parent (data not shown), we detected no significant difference
in either the recovery of infectious progeny from infected cells
(Figure S3B) or the average area of inclusions (Figure S3C)
upon restoring InaC expression in M407. When we incubated
WT, InaC-deficient, and InaC-restored infected cells with a
fluorescent ceramide analog and assessed the fluorescence
intensity of inclusions in live cells, we observed no significant dif-
ferences. As a control, we treated infected cells with Brefeldin A,
which inhibits sphingolipid acquisition by Chlamydia (Elwell
et al., 2011; Hackstadt et al., 1996), and observed a significant
decrease in the fluorescent ceramide acquisition (60%) in all
strains tested (Figures S3D and S3E). Collectively, these dataost & Microbe 17, 716–725, May 13, 2015 ª2015 Elsevier Inc. 721
demonstrate that InaC itself, including InaC-mediated ARF
recruitment and Golgi redistribution around the inclusion, is not
required for C. trachomatis replication, inclusion expansion,
and efficient sphingolipid trafficking to the inclusion in cultured
epithelial cells.
DISCUSSION
The first report of stable transformation of plasmid DNA
into Chlamydia (Wang et al., 2011) was a landmark event for
Chlamydiagenetics. Recently, a report describing targeted inser-
tionalmutagenesiswith type II introns (Johnson andFisher, 2013)
further suggested that modern molecular genetic approaches to
disrupt genes can be implemented in C. trachomatis. However,
these tools are not yet suitable to generate large collections
of mutant strains. With these limitations in mind, we devel-
oped a platform for forward and reverse genetic analysis in
C. trachomatis by generating and sequencing a collection of
934 chemically mutagenized strains. As the costs of genome
sequencing continue to plummet, there is a renewed interest in
the application of chemical and radiation-induced mutagenesis
as tools in microbial genetics. From the identification of suppres-
sors, adaptivemutations, and conditional alleles, pointmutations
provide a richer source of information for genetic analysis than
gene disruption strategies. It is in this context that the resource
we generated offers unique advantages, such as strains with
hypo- andhypermorphicmutations, includingmutations in genes
that are likely essential for infection. Furthermore, pointmutations
are unlikely to exhibit polar effects on the expression of other
genes within an operon, as is often observed during insertional
mutagenesis.
Mapping of all SNVs in the collection facilitated the identifica-
tion of strains bearing mutant alleles of interest. Indeed, mutants
from this collection have been recently characterized (Chen
et al., 2014; Snavely et al., 2014; Brown et al., 2014), underscor-
ing its utility in reverse genetic applications. Mutant strains were
sequenced in pools of 20 to lower the overall DNA sequencing
costs ($15/genome). To identify which strain within a pool
harbors a mutant allele of interest, each strain (which are individ-
ually arrayed) can be readily genotyped in a cost-effective
manner by standard PCR-based techniques such as TILLING
(Colbert et al., 2001; Kari et al., 2011; Supplemental Experi-
mental Procedures) or direct sequencing of amplicons spanning
the mutated region. Although the genome of the strain of interest
should be re-sequenced to identify accompanying mutations,
there is no need to sequence the genomes of additional mem-
bers of the original pool. Genetic linkage between amutant allele
and phenotype of interest can be established either by linkage
analysis (Nguyen and Valdivia, 2012) or by trans-complementa-
tion through plasmid transformation (Wang et al., 2011).
The mutant collection is well suited for forward genetic
screens. We described a screen for mutants impaired in F-
actin assembly at the inclusion and identified InaC, an inclusion
membrane protein that mediates F-actin reorganization, ARF
and 14-3-3 recruitment, and Golgi redistribution. InaC is highly
conserved in all serovars of C. trachomatis, including ocular,
genital, and LGV strains, and orthologs can be found in other
Chlamydiales. We determined that InaC recruits Golgi-specific
ARF GTPases and 14-3-3 proteins to the inclusion, both of722 Cell Host & Microbe 17, 716–725, May 13, 2015 ª2015 Elsevier Iwhich have been found to influence F-actin processes. For
instance, ARF1 at the Golgi stimulates actin assembly via
recruitment and regulation of Cdc42 (reviewed in Myers and
Casanova, 2008), and 14-3-3 proteins can modulate T cell
adhesion by binding to an intracellular region of integrins,
which are membrane receptors that bridge the intracellular
F-actin network and the extracellular matrix (Takala et al.,
2008). The precise mechanism by which InaC, presumably
through ARF and/or 14-3-3s interactions, regulates F-actin as-
sembly and Golgi redistribution at the inclusion remains to be
determined.
Cellular F-actin contributes to the stability of the inclusion
(Kumar and Valdivia, 2008) and to the extrusion of inclusions at
late stages of infection upon bacterial cell exit (Chin et al.,
2012; Hybiske and Stephens, 2007). Our findings indicate that
cellular F-actin and InaC-mediated F-actin structures at the in-
clusion are also required for Golgi redistribution to surround
the inclusion. The Golgi plays a central role in the secretory
pathway, which Chlamydia manipulates to intercept ER-synthe-
sized sphingolipids destined for the plasma membrane both by
engaging the ceramide transporter CERT at ER-inclusion mem-
brane contact sites (Derre´ et al., 2011; Elwell et al., 2011) and by
hijacking Golgi vesicular traffic (Elwell et al., 2011; Hackstadt
et al., 1995, 1996). Disruption of Golgi vesicular traffic and inter-
ference with ARF-regulated pathways using Brefeldin A or by
depletion of the ARF nucleotide exchange factor GBF1 disrupts
sphingolipid acquisition by bacteria (Elwell et al., 2011; Hack-
stadt et al., 1996). In addition to vesicular traffic, Golgi
morphology and localization may affect sphingolipid trafficking
to the inclusion since inhibition of Golgi dispersal during infection
using a caspase inhibitor or by depletion of Rab6 or Rab11
impairs sphingolipid acquisition by Chlamydia (Heuer et al.,
2009; Rejman Lipinski et al., 2009). Surprisingly, we find that
InaC-mediated Golgi redistribution or ARF recruitment does
not appear to have any discernable effect on the delivery of
sphingolipids to the inclusion.
Based on the analysis of nonsense mutations tolerated in the
mutagenized Chlamydia strains, we gained insights into this
pathogen’s metabolic requirements for completion of its infec-
tious cycle, including a limited role for a functional TCA cycle in
the LGV L2 biovar as previously suggested (Thomson et al.,
2008). In addition to the loss of fumC (fumerase) (Thomson
et al., 2008), the C. trachomatis lymphogranuloma biovars
can tolerate further degradation of the TCA cycle through
loss of SucA. These observations suggest that oxidative phos-
phorylation (respiration) in these biovars is not required for ATP
production. Instead, C. trachomatis L2 likely generates most of
its ATP by substrate-level phosphorylation (glycolysis) by taking
advantage of its efficient glycolytic (EMP) pathway that avoids
expenditure of two ATP molecules by importing glucose-6-
phosphate from the host through the UhpC transporter and
by utilizing inorganic pyrophosphate (PPi) as a phosphate
donor by the Chlamydia atypical phosphofructose kinase
(PfkAB) (Island et al., 1992; McClarty, 1999). Further evidence
for a bias against employing oxidative phosphorylation by
LGV C. trachomatis biovars comes from observations that the
succinate dehydrogenase cytochrome B subunit (SdhC), a cen-
tral component of the electron transport chain, is a pseudogene
(Thomson et al., 2008).nc.
Loss of oxidative phosphorylation would result in lower levels
of reactive oxygen species (ROS), a major byproduct of respira-
tion. This might be a desirable trait since C. trachomatis lacks
genes encoding the oxidative damage repair proteins MutT
and MutM (Stephens et al., 1998; Thomson et al., 2008). Low
levels of endogenous ROS might also increase tolerance to
oxidative bursts generated by immune cells allowing for LGV bio-
var strains to establish infections in human mononuclear phago-
cytes (MNPs) (Yong et al., 1987; Beagley et al., 2009).
In summary, we described a robust system for generating and
mapping mutations in the absence of classic molecular genetic
tools, which we have applied for genetic dissection of a complex
trait in Chlamydia. The methodology can be readily applied to
any microbe, even those that lack systems for genetic exchange
or DNA transformation, including emerging pathogens, outbreak
strains, and other experimentally intractable microbes.
EXPERIMENTAL PROCEDURES
A full description of Experimental Procedures is available in the Supplemental
Information.
Growth Condition, Cell Lines, and Chlamydia Strains
Vero cells (ATCC CCL-81), HeLa cells, and HEK293T cells were grown in high-
glucose DMEM supplemented with L-glutamine, sodium pyruvate (GIBCO,
Life Technologies), and 10% FBS (Mediatech, CellGro) at 37C in a 5% CO2
humidified incubator. C. trachomatis LGV biovar L2 434/Bu infections were
performed with EBs, synchronized by centrifugation (2,500 3 g for 30 min at
10C) onto Vero or HeLa cells, and incubated for indicated times. EB titers
were determined by assessing the number of inclusion forming units (IFUs)
with a Cellomics ArrayScan automated fluorescence imaging system (Thermo
Scientific).
Generation of a C. trachomatis LGV-L2 Mutant Library
Vero cells infected with RifR LGV-L2 (Nguyen and Valdivia, 2012) were muta-
genized with EMS and ENU (described in Nguyen and Valdivia, 2012).
Following mutagenesis, Vero cells seeded in 6-well plates were infected with
100 IFUs/well from independent pools of mutagenized EBs and, at 2 hpi, over-
laid with DMEM/agarose (0.5% SeaKem LE agarose [Lonza], 1 DMEM, 10%
FBS, 25 mg/ml gentamycin [GIBCO], 1X nonessential amino acids [GIBCO],
200 ng/ml cycloheximide [Sigma-Aldrich]). At 7–10 dpi, bacteria from small
plaques were harvested and expanded in Vero cells. Cell lysates containing
EBs were arrayed into 96-well plates to establish an ordered collection of
mutant strains and stored at 80C.
Genome Sequencing of C. trachomatis LGV-L2 Mutants
Vero cells in T25 flasks were infected with each mutant strain. At time of har-
vest, EBs were concentrated from cell lysates by centrifugation (21,000 3 g,
15 min, 4C) and resuspended in DNase I reaction buffer (NEB). Residual
host DNA was digested with 8 units of DNase I (NEB) for 1 hr at 37C, and
EBs were washed with PBS, pelleted, and resuspended in 180 ml of ATL buffer
(QIAGEN). Total DNA was isolated with a QIAGEN DNeasy Blood and Tissue
Kit (QIAGEN). A total of 150 ng of total DNA isolated from each of 20 individual
strainswere pooledwith 150 ng of control DNA.Onemicrogram of pooledDNA
was sheared with an Adaptive Focused Acoustics S220 instrument (Covaris).
Sequencing libraries were prepared and barcoded with a TrueSeq DNA sam-
ple preparation kit (Illumina Inc.) and sequenced on a HiSeq2000 sequencing
platform (Illumina Inc.).
Screen for Mutants Defective for F-Actin Assembly and
Identification of InaC
HeLa cells were grown to 50% confluence in 96-well plates and infected with
10 ml of crude cell lysates derived from cells infected with each mutant in the li-
brary or controlled amounts ofWTC. trachomatis. At 30hpi, cellswere fixedand
imaged as described below to assess F-actin at the periphery of inclusions.Cell HM407 was amplified from the library, subjected to WGS, and crossed with a
WT SpcR strain to generate recombinants as previously described (Nguyen
and Valdivia, 2012). Recombinants were assessed for F-actin assembly at
inclusions and genotyped for all M407-encoded SNVs (Colbert et al., 2001;
Kari et al., 2011) tomap thecausalmutation toCTL0184.M407was transformed
(Wanget al., 2011)with either an empty shuttle vector p2TK2-SW2 (Agaisse and
Derre´, 2013) or a vector containing WT CTL0184 and 250 bp of upstream
sequence.
Identification of Host Proteins that Interact with InaC
HEK293T cells were grown to 50%confluence in 10 cmdishes and transfected
with either a GFP-only or a plasmid encoding an N-terminally GFP-tagged full-
length InaC. At 24 hr post-transfection, cells were lysed in 25 mM Tris-HCl
(pH 8.0), 150 mM NaCl, 1 mM EDTA, and 0.5% NP-40 supplemented with a
protease inhibitor cocktail (Roche Diagnostics) and a phosphatase inhibitor
cocktail (Pierce), combined with GFP-Trap (ChromoTek) resin and incubated
overnight at 4C. Bound proteins were analyzed by LC-MS/MS at the Duke
Proteomics Core facility or eluted in 0.2 M glycine (pH 2.5), resolved by
SDS-PAGE, and subjected to immunoblot analysis.
Immunofluorescence and Quantitative Analysis
For high-magnification imaging, HeLa cells grown to 50% confluence on
glass coverslips were infected with the indicated C. trachomatis strains at
an MOI of 3. For ARF localization, cells were transfected with various
EGFP-ARF plasmids at the time of infection. At 30 hpi, cells were fixed
with 4% paraformaldehyde and permeabilized with cold 0.2% Triton
X-100. Samples were stained as indicated and images were captured on
an Axio Observer Z1 fluorescence microscope with a 63X objective (Zeiss).
For quantification, HeLa cells grown to 50% confluence in 96-well plates
were treated as above. As indicated, F-actin was depolymerized with a
30 min treatment of 500 nM Latrunculin B (Life Technologies) prior to fixation.
Cells were imaged with a Cellomics HTC Arrayscan (Thermo Scientific) using
a 20X objective, and images were viewed with Cellomics vHCS: View
Software v1.6 (Thermo Scientific) to quantify the number of inclusions sur-
rounded by F-actin or the number of cells with Golgi elements enveloping
inclusions. Alternatively, images were analyzed with a custom-designed al-
gorithm in Cellomics Scan Software v5.6 (Thermo Scientific) to quantify the
average intensity of F-actin at inclusions. Values from three technical tripli-
cate wells were combined in each of three independent experiments. Statis-
tically significant differences were assessed by Student’s t test or a one-way
ANOVA followed by Newman-Keuls Multiple Comparison post hoc analysis
with a p value < 0.05 considered significant.
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